Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biogen Acquires Rights to Eisai’s Alzheimer’s Drugs
Biogen Acquires Rights to Eisai’s Alzheimer’s Drugs
Biogen Acquires Rights to Eisai’s Alzheimer’s Drugs
Submitted by
admin
on March 5, 2014 - 8:58am
Source:
Bloomberg
News Tags:
Biogen Idec
Alzheimer's disease
Eisai
Headline:
Biogen Acquires Rights to Eisai’s Alzheimer’s Drugs
Do Not Allow Advertisers to Use My Personal information
